Design of a true bivalent ligand with picomolar affinity for a G protein-coupled receptor homodimer

Fecha de publicación

2026-01-23T14:17:16Z

2026-01-23T14:17:16Z

2018-10-25

2026-01-23T14:17:16Z



Resumen

Bivalent ligands have emerged as chemical tools to study G protein-coupled receptor dimers. Using a combination of computational, chemical, and biochemical tools, here we describe the design of bivalent ligand 13 with high affinity (KDB1=21 pM) for the dopa-mine D2 receptor (D2R) homodimer. Bivalent ligand 13 enhances the binding affinity relative to monovalent compound 15 by 37-fold, indicating simultaneous binding at both protomers. Using synthetic peptides with amino acid sequences of transmembrane (TM) domains of D2R, we provide evidence that TM6 forms the interface of the homodimer. Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand 13 by 52-fold and had no effect on monovalent compound 15, confirming the D2R homodimer through TM6 ex-vivo. In conclusion, using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D2R homodimer

Tipo de documento

Artículo


Versión aceptada

Lengua

Inglés

Publicado por

American Chemical Society

Documentos relacionados

Versió postprint del document publicat a: https://doi.org/10.1021/acs.jmedchem.8b01249

Journal of Medicinal Chemistry, 2018, vol. 61, num.20, p. 9335-9346

https://doi.org/10.1021/acs.jmedchem.8b01249

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

(c) American Chemical Society, 2018

Este ítem aparece en la(s) siguiente(s) colección(ones)